Orca Bio
Jacquie Kim currently serves as the Director of Validation at Orca Bio since August 2021. Prior to this role, Jacquie held the position of Associate Director of QA Validation at Sangamo Therapeutics, Inc., where responsibilities included providing quality guidance for a greenfield gene and cell therapy facility buildout and implementing a validation program. Jacquie's experience also includes consulting roles at JJK Consulting, assessing Quality Assurance programs and cGMP compliance, and positions at Samsung Biologics and Novartis focusing on validation management and consulting. Jacquie holds a degree in Molecular Cell Biology with an emphasis in Biochemistry from the University of California, Berkeley.
This person is not in any teams
This person is not in any offices
Orca Bio
3 followers
Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients’ diseased blood and immune system with a healthy one. Their manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling them to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy. Their talented team is driven by a passion for science and compassion for patients.